| Karen M Sullivan, PT | |
|
2295 Diamond Hill Rd, Cumberland, RI 02864-5104 | |
| (401) 333-9787 | |
| (401) 333-9785 |
| Full Name | Karen M Sullivan |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 38 Years |
| Location | 2295 Diamond Hill Rd, Cumberland, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174638415 | NPI | - | NPPES |
| 6025 | Other | MA | STATE LICENSE |
| PT00956 | Other | RI | STATE LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT00956 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tycam Rehab Inc | 5092017046 | 3 |
News Archive
For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.
Scientists from the Universities of Dundee and St Andrews have won a major new research grant to develop a completely new technology for delivering cell-by-cell medical treatments.
MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers for cancer diagnostics.
› Verified 7 days ago
| Provider Name | Tycam Rehab Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1801267950 PECOS PAC ID: 5092017046 Enrollment ID: O20160107000892 |
News Archive
For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.
Scientists from the Universities of Dundee and St Andrews have won a major new research grant to develop a completely new technology for delivering cell-by-cell medical treatments.
MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers for cancer diagnostics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen M Sullivan, PT Po Box 20372, Cranston, RI 02920-0944 Ph: (401) 785-1016 | Karen M Sullivan, PT 2295 Diamond Hill Rd, Cumberland, RI 02864-5104 Ph: (401) 333-9787 |
News Archive
For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.
Scientists from the Universities of Dundee and St Andrews have won a major new research grant to develop a completely new technology for delivering cell-by-cell medical treatments.
MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers for cancer diagnostics.
› Verified 7 days ago
Mr. Michael Dudley Shaw, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2138 Mendon Rd, #302, Cumberland, RI 02864 Phone: 401-334-0218 Fax: 401-334-9531 | |
Lepre Pt Of Cumberland Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2295 Diamond Hill Rd, Cumberland, RI 02864 Phone: 401-333-9787 Fax: 401-333-9785 | |
Bizzy Bees Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 30 Martin St Unit 4-3, Cumberland, RI 02864 Phone: 401-225-7728 Fax: 401-644-6141 | |
Tina Deroy, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Chambers Street, Cumberland, RI 02864 Phone: 401-724-7500 | |
Mr. Francis George, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 High Ridge Dr, Cumberland, RI 02864 Phone: 401-333-6155 | |
Cynthia Carter, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Chambers St, Cumberland, RI 02864 Phone: 401-724-7500 |